
Epirubicin Hydrochloride
Form: Injection (IV)
Strength: 10 mg/5 mL, 50 mg/25 mL, 100 mg/50 mL
Reference Brands: Ellence® (US) , Farmorubicin®(EU)
Category: Oncology Cancer Care
Epirubicin Hydrochloride is a potent anthracycline chemotherapy agent widely used in treating breast, gastric, ovarian, lung, and bladder cancers. It works by inhibiting DNA synthesis, leading to effective cancer cell destruction. Available under brand names like Ellence® (US) and Farmorubicin® (EU), and in generic forms, Epirubicin is supplied as an IV injection in 10 mg, 50 mg, and 100 mg vial strengths. Manufactured in GMP-compliant facilities, it is ideal for hospital oncology departments and global pharmaceutical distributors. Epirubicin remains a trusted cancer treatment solution across EU and US markets, ensuring consistent quality and therapeutic efficacy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View Details Get EnquiryDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View Details Get EnquirySunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View Details Get EnquiryIfosfamide
Strength: 1 g/vial,2 g/vial, 3 g/vial
Form: Injection
Reference Brands: Ifex® (US), Holoxan® (EU)
View Details Get Enquiry